New horizons: does mineralocorticoid receptor activation by cortisol cause ATP release and COVID-19 complications?

C Edwards - The Journal of Clinical Endocrinology & …, 2021 - academic.oup.com
This paper attempts to explain how the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) virus causes the complications that make coronavirus disease 2019 (COVID …

The COVID-19 pandemic requires a unified global response

S Filetti - Endocrine, 2020 - Springer
The ongoing spread of the COVID-19 pandemic is having profound effects on our private
and professional lives, the world economy, and the social organization of the communities …

Pathogenic connections in post-COVID conditions: What do we know in the large unknown? A narrative review

CS Stafie, SM Solomon, IG Sufaru, M Manaila, II Stafie… - Viruses, 2022 - mdpi.com
The coronavirus 2019 (COVID-19) disease has long-term effects, known as post-COVID
conditions (PCC) or long-COVID. Post-COVID-19 syndrome is defined by signs and …

Male pituitary–gonadal axis dysfunction in post‐acute COVID‐19 syndrome—Prevalence and associated factors: A Mediterranean case series

O Moreno‐Perez, E Merino, R Alfayate… - Clinical …, 2022 - Wiley Online Library
Objective Severe acute respiratory syndrome coronavirus 2 through angiotensin‐converting
enzyme 2 receptor can harm testes function. The objectives were to analyse the prevalence …

[HTML][HTML] COVID-19 and progesterone: Part 1. SARS-CoV-2, progesterone and its potential clinical use

SB Shah - Endocrine and metabolic science, 2021 - Elsevier
Abstract SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection is a
global medical challenge. Experience based medicines and therapies are being attempted …

Sympathetic activation: a potential link between comorbidities and COVID‐19

A Porzionato, A Emmi, S Barbon… - The FEBS …, 2020 - Wiley Online Library
In coronavirus disease 2019 (COVID‐19), higher morbidity and mortality are associated with
age, male gender, and comorbidities, such as chronic lung diseases, cardiovascular …

Post-COVID-19 condition: where are we now?

P Boaventura, S Macedo, F Ribeiro, S Jaconiano… - Life, 2022 - mdpi.com
COVID-19 is currently considered a systemic infection involving multiple systems and
causing chronic complications. Compared to other post-viral fatigue syndromes, these …

Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection (PASC) neurologic symptoms: A case-control pilot study

TJ Wright, RB Pyles, M Sheffield-Moore… - Molecular and Cellular …, 2024 - Elsevier
Objective To determine if patients that develop lingering neurologic symptoms of fatigue and
“brain fog” after initial recovery from coronavirus disease 2019 (COVID-19) have persistent …

Understanding the link between obesity and severe COVID-19 outcomes: causal mediation by systemic inflammatory response

AS Foulkes, C Selvaggi, D Shinnick… - The Journal of …, 2022 - academic.oup.com
Background Obesity is an established risk factor for severe COVID-19 outcomes. The
mechanistic underpinnings of this association are not well-understood. Objective To …

Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2

MJ Young, CD Clyne… - Journal of …, 2020 - joe.bioscientifica.com
Coronavirus disease (COVID-19) is caused by a new strain of coronavirus, the severe acute
respiratory syndrome coronavirus 2 or SARS-CoV-2. At the time of writing, SARS-CoV-2 has …